Search
forResearch 10 of 1000+
- Oral finasteride use and sexual adverse events: signal detection from disproportionality analyses of data from the United States Food and Drug Administration Adverse Event Reporting System
- Long-term treatment with finasteride: sexual adverse events and fracture rates
- Sexual adverse events-related to dutasteride e finasteride: analysis of real-life data from Eudra-Vigilance database
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs
- Case reports suggest a broader range of sexual adverse events in patients receiving finasteride [Propecia, Proscar] than previously reported,
- Assessing dutasteride-associated sexual dysfunction using the U.S. Food and Drug Administration Adverse Event Reporting System
- A Gender Hypothesis of sex disparities in adverse drug events
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
Community 4 of 144
- 5ARi of choice not working yet? Paper Review for efficacy + safety
- Why are low finasteride doses seen as highly ineffective, when studies show 0.05 mg/day to work?
- GT20029 - Promising phase II results
- Minoxadil 5% wv topical only? Experienced sides on 1mg fin and ~0.25mg fin. Solutions from here
Learn
— no results
Try a deeper search in learn →